Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ipsen S.A. | 1 | 0 | 0 | 0 | €109.80 | €109.00 | -0.729% |
| GSK plc ADR | 5 | 0 | 0 | 0 | €38.40 | €49.33 | 28.456% |
| Laboratory Corp. Of America (labcorp) | 13 | 0 | 0 | 0 | €197.00 | €238.58 | 21.106% |
| Grifols S.A. | 1 | 0 | 0 | 0 | €10.20 | - | - |
| Becton, Dickinson & Co. | 10 | 0 | 0 | 0 | €208.60 | €257.91 | 23.638% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €194.10 | - | - |
| Fresenius SE & Co. KGaA | 3 | 0 | 0 | 0 | €34.13 | - | - |
| Steris Corp. | 1 | 0 | 0 | 0 | €218.00 | - | - |
| Koninklijke Philips Electronics ADR | 3 | 1 | 0 | 0 | €27.40 | - | - |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €141.95 | €165.00 | 16.238% |
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €14.27 | - | - |
| Smith & Nephew plc ADR | 3 | 0 | 0 | 0 | €27.60 | - | - |
| Teleflex Inc. | 11 | 0 | 0 | 0 | €216.00 | €245.97 | 13.873% |
| Elanco Animal Health Inc. | 8 | 2 | 0 | 0 | €13.06 | €16.17 | 23.810% |
| Merck KGaA | 4 | 1 | 0 | 0 | €166.25 | €172.00 | 3.459% |
| Henry Schein Inc. | 15 | 1 | 0 | 0 | €65.26 | €76.08 | 16.579% |
| Novartis AG ADR | 3 | 0 | 0 | 0 | €104.50 | €112.40 | 7.557% |
| Amgen Inc. | 28 | 0 | 0 | 0 | €299.70 | €304.82 | 1.708% |
| Baxter International | 3 | 0 | 0 | 0 | €35.46 | €46.00 | 29.728% |
| Quest Diagnostics Inc. | 7 | 0 | 0 | 0 | €139.80 | €145.02 | 3.732% |
| Resmed Inc. | 19 | 1 | 0 | 1 | €214.20 | €215.13 | 0.433% |
| Idexx Laboratories Inc. | 12 | 0 | 0 | 0 | €460.20 | €554.23 | 20.432% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €103.10 | €109.00 | 5.723% |
| Dentsply Sirona Inc. | 17 | 0 | 1 | 0 | €24.05 | €35.04 | 45.696% |
| Roche Holding AG ADR | 4 | 3 | 1 | 1 | €35.40 | €38.00 | 7.357% |